Amycretin is a unimolecular long-acting GLP-1 and amylin receptor agonist under development by Novo Nordisk, to provide an ...

Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...

By automating key financial and operational functions, LabConnect will increase efficiency and position itself for rapid global scaling. “As we continue to expand our global footprint, this ERP ...

IHL-42X is designed to treat obstructive sleep apnea ("OSA”) by targeting its underlying pathophysiology. An oral fixed-dose combination of dronabinol and acetazolamide, IHL-42X is currently advancing ...

Health Secretary Robert F. Kennedy Jr. announced a slate of eight new members to serve on the Advisory Committee on ...

Latest evidence from the world's longest running study on myopia management spectacle lenses reinforced the effectiveness of Defocus Incorporated ...

Read an interview with a former nurse about failings at the Countess of Chester's neonatal unit, some of which predated Lucy ...